Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ

Cancer Research

Volumn 62, Issue 6, 2002, Pages 1676-1681

  Half, Elizabeth ^a   Tang, Xi Ming ^a   Gwyn, Karin ^a   Sahin, Aysegul ^a   Wathen, Kyle ^a   Sinicrope, Frank A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2 INHIBITOR; MESSENGER RNA; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; RNA;

ADULT; AGED; ARTICLE; BREAST CANCER; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CYCLOOXYGENASE 2; FEMALE; GENE AMPLIFICATION; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM STAGING; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0037086261     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines
2. 2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators
3. Prostaglandins in human breast cancer: Evidence suggesting that elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells
4. Prostaglandins in breast cancer. Relationship to disease stage and hormone status
5. Prostaglandin endoperoxide H synthase (cyclooxygenase)-1 and -2
6. Molecular cloning of human prostaglandin endoperoxidase synthase type 2 and demonstration of expression in response to cytokines
7. Up-regulation of cyclooxygenase gene expression in human colorectal adenomas and adenocarcinomas
8. Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers
9. Expression of cyclooxygenase-2 in human gastric carcinoma
10. Cyclooxygenase-2 expression in human esophageal carcinoma
11. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas
12. Increased expression of cyclooxygenase-2 occurs frequently in human lung cancers, specifically in adenocarcinomas
13. Cyclooxygenase-2 gene expression is upregulated in transformed mammary epithelial cells
14. Cyclooxygenase-2 gene expression in human breast cancer
15. COX-2 is expressed in human pulmonary, colonic, and mammary tumors
16. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer
17. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice
18. Suppression of intestinal polyposis in Apc716 knockout mice by inhibition of cyclooxygenase-2 (COX-2)
19. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor
20. Chemoprevention by nimesulide, a selective cyclooxygenase-2 inhibitor, of 2-amino-1-methyl-6-phenylimidazo[4,5,-b]pyridine (PhlP)-induced mammary gland carcinogenesis in rats
21. Chemotherapeutic evaluation of celecoxib, a cyclooxygenase-2 inhibitor, in rats mammary tumor model
22. Cancer statistics, 2001
23. Aspirin use and lung, colon, and breast cancer. Incidence in a prospective study
24. Non-steroidal anti-inflammatory drugs and breast cancer
25. Nested case control study of the effect of non-steroidal anti-inflammatory drugs on breast cancer risk and stage
26. Prospective study of regular aspirin use and the risk of breast cancer
27. A hypothesis: Nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer
28. Aspirin use and reduced risk of fatal colon cancer
29. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals
30. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
31. Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam
32. Sulindac prevents tumors in a murine model of familial adenomatous polyposis
33. Modulation of rat mammary carcinogenesis by indomethacin
34. Effects of prostaglandin synthetase inhibitor indomethacin on tumorigenesis, tumor proliferation, cell kinetics, and receptor contents of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in Sprague-Dawley rats fed a high or low fat diet
35. A comparison of the effects of prostaglandin synthesis inhibitors indomethacin and carprofen on 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats fed different amounts of essential fatty acids
36. Comparative chemopreventive activity of ibuprofen and N-(4-hydroxyphenyl)retinamide against the development and growth of rat mammary adenocarcinomas
37. Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas
38. Chemoprevention of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mammary carcinogenesis in rats
39. Inhibition of mammary carcinogenesis by flurbiprofen, a non-steroidal anti-inflammatory agent
40. Effects of D,L-2-difluoromethylornithine and indomethacin on mammary tumors promotion in rats fed high n-3 and/or n-6 fat diets
41. Comparative effects of piroxicam and esculetin on incidence, proliferation, and cell kinetics of mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene in rats on high and low fat diets
42. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
43. Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors
44. Regulation of cyclooxygenase-2 pathway by HER2 receptor
45. Evaluation of TNM classification of carcinoma of the breast
46. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers
47. Studies of human breast cancer metastasis using nude mice
48. Anti-HER2 antibody enhances the growth inhibitory effect of anti-oestrogen on breast cancer cells expressing both oestrogen receptors and HER2
49. Immunohistochemical detection of the neu protein in tissue sections of human breast tumors with amplified neu DNA
50. Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth
51. Alteration in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
52. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis
53. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polylposis